Serological and Molecular Prevalence of <em<Babesia caballi</em< in Apparently Healthy Horses in Israel
<i<Babesia caballi</i< is a tick-borne hemoparasite of equines and one of the causative agents of equine piroplasmosis, which poses a great concern for the equine industry regarding animal welfare and international horse movement. The parasite is endemic in Israel; however, its seropreva...
Ausführliche Beschreibung
Autor*in: |
Sharon Tirosh-Levy [verfasserIn] Monica L. Mazuz [verfasserIn] Igor Savitsky [verfasserIn] Dana Pinkas [verfasserIn] Yuval Gottlieb [verfasserIn] Amir Steinman [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2021 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Pathogens - MDPI AG, 2012, 10(2021), 4, p 445 |
---|---|
Übergeordnetes Werk: |
volume:10 ; year:2021 ; number:4, p 445 |
Links: |
---|
DOI / URN: |
10.3390/pathogens10040445 |
---|
Katalog-ID: |
DOAJ031234720 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ031234720 | ||
003 | DE-627 | ||
005 | 20240412184710.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230226s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/pathogens10040445 |2 doi | |
035 | |a (DE-627)DOAJ031234720 | ||
035 | |a (DE-599)DOAJb3cca79427944cc09f98a5fbb03a7659 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a Sharon Tirosh-Levy |e verfasserin |4 aut | |
245 | 1 | 0 | |a Serological and Molecular Prevalence of <em<Babesia caballi</em< in Apparently Healthy Horses in Israel |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a <i<Babesia caballi</i< is a tick-borne hemoparasite of equines and one of the causative agents of equine piroplasmosis, which poses a great concern for the equine industry regarding animal welfare and international horse movement. The parasite is endemic in Israel; however, its seroprevalence in the area was never evaluated due to antigenic heterogenicity in the gene used in the commercially available kit. Blood samples were collected from 257 horses at 19 farms throughout the country and screened for the presence of anti-<i<B. caballi</i< antibodies via an indirect immunofluorescent antibody test (IFAT) and for the presence of parasite DNA by nested PCR. The seroprevalence of <i<B. caballi</i< was 69.6% and its molecular prevalence was 9.7%. The geographical area, horse’s sex, breed, housing, exposure to ticks, and specifically to <i<Hyalomma marginatum</i<, and co-infection with <i<Theileria equi</i< were found to be significantly associated with serologic exposure in univariable analysis, while the geographical area and horses’ sex remained significant in the multivariable analysis. The results of this study demonstrate a high level of exposure to <i<B. caballi</i< and identify important risk factors for infection. The difference between the serological and molecular prevalence, probably related to parasite clearance, is also highlighted. | ||
650 | 4 | |a equine piroplasmosis | |
650 | 4 | |a <i<Babesia caballi</i< | |
650 | 4 | |a IFAT | |
650 | 4 | |a nested PCR | |
650 | 4 | |a risk factors | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
700 | 0 | |a Monica L. Mazuz |e verfasserin |4 aut | |
700 | 0 | |a Igor Savitsky |e verfasserin |4 aut | |
700 | 0 | |a Dana Pinkas |e verfasserin |4 aut | |
700 | 0 | |a Yuval Gottlieb |e verfasserin |4 aut | |
700 | 0 | |a Amir Steinman |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Pathogens |d MDPI AG, 2012 |g 10(2021), 4, p 445 |w (DE-627)732627885 |w (DE-600)2695572-6 |x 20760817 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2021 |g number:4, p 445 |
856 | 4 | 0 | |u https://doi.org/10.3390/pathogens10040445 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/b3cca79427944cc09f98a5fbb03a7659 |z kostenfrei |
856 | 4 | 0 | |u https://www.mdpi.com/2076-0817/10/4/445 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2076-0817 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 10 |j 2021 |e 4, p 445 |
author_variant |
s t l stl m l m mlm i s is d p dp y g yg a s as |
---|---|
matchkey_str |
article:20760817:2021----::eooiaadoeuapeaecoebbsaaaleiaprn |
hierarchy_sort_str |
2021 |
publishDate |
2021 |
allfields |
10.3390/pathogens10040445 doi (DE-627)DOAJ031234720 (DE-599)DOAJb3cca79427944cc09f98a5fbb03a7659 DE-627 ger DE-627 rakwb eng Sharon Tirosh-Levy verfasserin aut Serological and Molecular Prevalence of <em<Babesia caballi</em< in Apparently Healthy Horses in Israel 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <i<Babesia caballi</i< is a tick-borne hemoparasite of equines and one of the causative agents of equine piroplasmosis, which poses a great concern for the equine industry regarding animal welfare and international horse movement. The parasite is endemic in Israel; however, its seroprevalence in the area was never evaluated due to antigenic heterogenicity in the gene used in the commercially available kit. Blood samples were collected from 257 horses at 19 farms throughout the country and screened for the presence of anti-<i<B. caballi</i< antibodies via an indirect immunofluorescent antibody test (IFAT) and for the presence of parasite DNA by nested PCR. The seroprevalence of <i<B. caballi</i< was 69.6% and its molecular prevalence was 9.7%. The geographical area, horse’s sex, breed, housing, exposure to ticks, and specifically to <i<Hyalomma marginatum</i<, and co-infection with <i<Theileria equi</i< were found to be significantly associated with serologic exposure in univariable analysis, while the geographical area and horses’ sex remained significant in the multivariable analysis. The results of this study demonstrate a high level of exposure to <i<B. caballi</i< and identify important risk factors for infection. The difference between the serological and molecular prevalence, probably related to parasite clearance, is also highlighted. equine piroplasmosis <i<Babesia caballi</i< IFAT nested PCR risk factors Medicine R Monica L. Mazuz verfasserin aut Igor Savitsky verfasserin aut Dana Pinkas verfasserin aut Yuval Gottlieb verfasserin aut Amir Steinman verfasserin aut In Pathogens MDPI AG, 2012 10(2021), 4, p 445 (DE-627)732627885 (DE-600)2695572-6 20760817 nnns volume:10 year:2021 number:4, p 445 https://doi.org/10.3390/pathogens10040445 kostenfrei https://doaj.org/article/b3cca79427944cc09f98a5fbb03a7659 kostenfrei https://www.mdpi.com/2076-0817/10/4/445 kostenfrei https://doaj.org/toc/2076-0817 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2021 4, p 445 |
spelling |
10.3390/pathogens10040445 doi (DE-627)DOAJ031234720 (DE-599)DOAJb3cca79427944cc09f98a5fbb03a7659 DE-627 ger DE-627 rakwb eng Sharon Tirosh-Levy verfasserin aut Serological and Molecular Prevalence of <em<Babesia caballi</em< in Apparently Healthy Horses in Israel 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <i<Babesia caballi</i< is a tick-borne hemoparasite of equines and one of the causative agents of equine piroplasmosis, which poses a great concern for the equine industry regarding animal welfare and international horse movement. The parasite is endemic in Israel; however, its seroprevalence in the area was never evaluated due to antigenic heterogenicity in the gene used in the commercially available kit. Blood samples were collected from 257 horses at 19 farms throughout the country and screened for the presence of anti-<i<B. caballi</i< antibodies via an indirect immunofluorescent antibody test (IFAT) and for the presence of parasite DNA by nested PCR. The seroprevalence of <i<B. caballi</i< was 69.6% and its molecular prevalence was 9.7%. The geographical area, horse’s sex, breed, housing, exposure to ticks, and specifically to <i<Hyalomma marginatum</i<, and co-infection with <i<Theileria equi</i< were found to be significantly associated with serologic exposure in univariable analysis, while the geographical area and horses’ sex remained significant in the multivariable analysis. The results of this study demonstrate a high level of exposure to <i<B. caballi</i< and identify important risk factors for infection. The difference between the serological and molecular prevalence, probably related to parasite clearance, is also highlighted. equine piroplasmosis <i<Babesia caballi</i< IFAT nested PCR risk factors Medicine R Monica L. Mazuz verfasserin aut Igor Savitsky verfasserin aut Dana Pinkas verfasserin aut Yuval Gottlieb verfasserin aut Amir Steinman verfasserin aut In Pathogens MDPI AG, 2012 10(2021), 4, p 445 (DE-627)732627885 (DE-600)2695572-6 20760817 nnns volume:10 year:2021 number:4, p 445 https://doi.org/10.3390/pathogens10040445 kostenfrei https://doaj.org/article/b3cca79427944cc09f98a5fbb03a7659 kostenfrei https://www.mdpi.com/2076-0817/10/4/445 kostenfrei https://doaj.org/toc/2076-0817 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2021 4, p 445 |
allfields_unstemmed |
10.3390/pathogens10040445 doi (DE-627)DOAJ031234720 (DE-599)DOAJb3cca79427944cc09f98a5fbb03a7659 DE-627 ger DE-627 rakwb eng Sharon Tirosh-Levy verfasserin aut Serological and Molecular Prevalence of <em<Babesia caballi</em< in Apparently Healthy Horses in Israel 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <i<Babesia caballi</i< is a tick-borne hemoparasite of equines and one of the causative agents of equine piroplasmosis, which poses a great concern for the equine industry regarding animal welfare and international horse movement. The parasite is endemic in Israel; however, its seroprevalence in the area was never evaluated due to antigenic heterogenicity in the gene used in the commercially available kit. Blood samples were collected from 257 horses at 19 farms throughout the country and screened for the presence of anti-<i<B. caballi</i< antibodies via an indirect immunofluorescent antibody test (IFAT) and for the presence of parasite DNA by nested PCR. The seroprevalence of <i<B. caballi</i< was 69.6% and its molecular prevalence was 9.7%. The geographical area, horse’s sex, breed, housing, exposure to ticks, and specifically to <i<Hyalomma marginatum</i<, and co-infection with <i<Theileria equi</i< were found to be significantly associated with serologic exposure in univariable analysis, while the geographical area and horses’ sex remained significant in the multivariable analysis. The results of this study demonstrate a high level of exposure to <i<B. caballi</i< and identify important risk factors for infection. The difference between the serological and molecular prevalence, probably related to parasite clearance, is also highlighted. equine piroplasmosis <i<Babesia caballi</i< IFAT nested PCR risk factors Medicine R Monica L. Mazuz verfasserin aut Igor Savitsky verfasserin aut Dana Pinkas verfasserin aut Yuval Gottlieb verfasserin aut Amir Steinman verfasserin aut In Pathogens MDPI AG, 2012 10(2021), 4, p 445 (DE-627)732627885 (DE-600)2695572-6 20760817 nnns volume:10 year:2021 number:4, p 445 https://doi.org/10.3390/pathogens10040445 kostenfrei https://doaj.org/article/b3cca79427944cc09f98a5fbb03a7659 kostenfrei https://www.mdpi.com/2076-0817/10/4/445 kostenfrei https://doaj.org/toc/2076-0817 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2021 4, p 445 |
allfieldsGer |
10.3390/pathogens10040445 doi (DE-627)DOAJ031234720 (DE-599)DOAJb3cca79427944cc09f98a5fbb03a7659 DE-627 ger DE-627 rakwb eng Sharon Tirosh-Levy verfasserin aut Serological and Molecular Prevalence of <em<Babesia caballi</em< in Apparently Healthy Horses in Israel 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <i<Babesia caballi</i< is a tick-borne hemoparasite of equines and one of the causative agents of equine piroplasmosis, which poses a great concern for the equine industry regarding animal welfare and international horse movement. The parasite is endemic in Israel; however, its seroprevalence in the area was never evaluated due to antigenic heterogenicity in the gene used in the commercially available kit. Blood samples were collected from 257 horses at 19 farms throughout the country and screened for the presence of anti-<i<B. caballi</i< antibodies via an indirect immunofluorescent antibody test (IFAT) and for the presence of parasite DNA by nested PCR. The seroprevalence of <i<B. caballi</i< was 69.6% and its molecular prevalence was 9.7%. The geographical area, horse’s sex, breed, housing, exposure to ticks, and specifically to <i<Hyalomma marginatum</i<, and co-infection with <i<Theileria equi</i< were found to be significantly associated with serologic exposure in univariable analysis, while the geographical area and horses’ sex remained significant in the multivariable analysis. The results of this study demonstrate a high level of exposure to <i<B. caballi</i< and identify important risk factors for infection. The difference between the serological and molecular prevalence, probably related to parasite clearance, is also highlighted. equine piroplasmosis <i<Babesia caballi</i< IFAT nested PCR risk factors Medicine R Monica L. Mazuz verfasserin aut Igor Savitsky verfasserin aut Dana Pinkas verfasserin aut Yuval Gottlieb verfasserin aut Amir Steinman verfasserin aut In Pathogens MDPI AG, 2012 10(2021), 4, p 445 (DE-627)732627885 (DE-600)2695572-6 20760817 nnns volume:10 year:2021 number:4, p 445 https://doi.org/10.3390/pathogens10040445 kostenfrei https://doaj.org/article/b3cca79427944cc09f98a5fbb03a7659 kostenfrei https://www.mdpi.com/2076-0817/10/4/445 kostenfrei https://doaj.org/toc/2076-0817 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2021 4, p 445 |
allfieldsSound |
10.3390/pathogens10040445 doi (DE-627)DOAJ031234720 (DE-599)DOAJb3cca79427944cc09f98a5fbb03a7659 DE-627 ger DE-627 rakwb eng Sharon Tirosh-Levy verfasserin aut Serological and Molecular Prevalence of <em<Babesia caballi</em< in Apparently Healthy Horses in Israel 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <i<Babesia caballi</i< is a tick-borne hemoparasite of equines and one of the causative agents of equine piroplasmosis, which poses a great concern for the equine industry regarding animal welfare and international horse movement. The parasite is endemic in Israel; however, its seroprevalence in the area was never evaluated due to antigenic heterogenicity in the gene used in the commercially available kit. Blood samples were collected from 257 horses at 19 farms throughout the country and screened for the presence of anti-<i<B. caballi</i< antibodies via an indirect immunofluorescent antibody test (IFAT) and for the presence of parasite DNA by nested PCR. The seroprevalence of <i<B. caballi</i< was 69.6% and its molecular prevalence was 9.7%. The geographical area, horse’s sex, breed, housing, exposure to ticks, and specifically to <i<Hyalomma marginatum</i<, and co-infection with <i<Theileria equi</i< were found to be significantly associated with serologic exposure in univariable analysis, while the geographical area and horses’ sex remained significant in the multivariable analysis. The results of this study demonstrate a high level of exposure to <i<B. caballi</i< and identify important risk factors for infection. The difference between the serological and molecular prevalence, probably related to parasite clearance, is also highlighted. equine piroplasmosis <i<Babesia caballi</i< IFAT nested PCR risk factors Medicine R Monica L. Mazuz verfasserin aut Igor Savitsky verfasserin aut Dana Pinkas verfasserin aut Yuval Gottlieb verfasserin aut Amir Steinman verfasserin aut In Pathogens MDPI AG, 2012 10(2021), 4, p 445 (DE-627)732627885 (DE-600)2695572-6 20760817 nnns volume:10 year:2021 number:4, p 445 https://doi.org/10.3390/pathogens10040445 kostenfrei https://doaj.org/article/b3cca79427944cc09f98a5fbb03a7659 kostenfrei https://www.mdpi.com/2076-0817/10/4/445 kostenfrei https://doaj.org/toc/2076-0817 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2021 4, p 445 |
language |
English |
source |
In Pathogens 10(2021), 4, p 445 volume:10 year:2021 number:4, p 445 |
sourceStr |
In Pathogens 10(2021), 4, p 445 volume:10 year:2021 number:4, p 445 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
equine piroplasmosis <i<Babesia caballi</i< IFAT nested PCR risk factors Medicine R |
isfreeaccess_bool |
true |
container_title |
Pathogens |
authorswithroles_txt_mv |
Sharon Tirosh-Levy @@aut@@ Monica L. Mazuz @@aut@@ Igor Savitsky @@aut@@ Dana Pinkas @@aut@@ Yuval Gottlieb @@aut@@ Amir Steinman @@aut@@ |
publishDateDaySort_date |
2021-01-01T00:00:00Z |
hierarchy_top_id |
732627885 |
id |
DOAJ031234720 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ031234720</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240412184710.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/pathogens10040445</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ031234720</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJb3cca79427944cc09f98a5fbb03a7659</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Sharon Tirosh-Levy</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Serological and Molecular Prevalence of <em<Babesia caballi</em< in Apparently Healthy Horses in Israel</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a"><i<Babesia caballi</i< is a tick-borne hemoparasite of equines and one of the causative agents of equine piroplasmosis, which poses a great concern for the equine industry regarding animal welfare and international horse movement. The parasite is endemic in Israel; however, its seroprevalence in the area was never evaluated due to antigenic heterogenicity in the gene used in the commercially available kit. Blood samples were collected from 257 horses at 19 farms throughout the country and screened for the presence of anti-<i<B. caballi</i< antibodies via an indirect immunofluorescent antibody test (IFAT) and for the presence of parasite DNA by nested PCR. The seroprevalence of <i<B. caballi</i< was 69.6% and its molecular prevalence was 9.7%. The geographical area, horse’s sex, breed, housing, exposure to ticks, and specifically to <i<Hyalomma marginatum</i<, and co-infection with <i<Theileria equi</i< were found to be significantly associated with serologic exposure in univariable analysis, while the geographical area and horses’ sex remained significant in the multivariable analysis. The results of this study demonstrate a high level of exposure to <i<B. caballi</i< and identify important risk factors for infection. The difference between the serological and molecular prevalence, probably related to parasite clearance, is also highlighted.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">equine piroplasmosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<Babesia caballi</i<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">IFAT</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">nested PCR</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">risk factors</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Monica L. Mazuz</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Igor Savitsky</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Dana Pinkas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yuval Gottlieb</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Amir Steinman</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Pathogens</subfield><subfield code="d">MDPI AG, 2012</subfield><subfield code="g">10(2021), 4, p 445</subfield><subfield code="w">(DE-627)732627885</subfield><subfield code="w">(DE-600)2695572-6</subfield><subfield code="x">20760817</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:4, p 445</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/pathogens10040445</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/b3cca79427944cc09f98a5fbb03a7659</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/2076-0817/10/4/445</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2076-0817</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">2021</subfield><subfield code="e">4, p 445</subfield></datafield></record></collection>
|
author |
Sharon Tirosh-Levy |
spellingShingle |
Sharon Tirosh-Levy misc equine piroplasmosis misc <i<Babesia caballi</i< misc IFAT misc nested PCR misc risk factors misc Medicine misc R Serological and Molecular Prevalence of <em<Babesia caballi</em< in Apparently Healthy Horses in Israel |
authorStr |
Sharon Tirosh-Levy |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)732627885 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
20760817 |
topic_title |
Serological and Molecular Prevalence of <em<Babesia caballi</em< in Apparently Healthy Horses in Israel equine piroplasmosis <i<Babesia caballi</i< IFAT nested PCR risk factors |
topic |
misc equine piroplasmosis misc <i<Babesia caballi</i< misc IFAT misc nested PCR misc risk factors misc Medicine misc R |
topic_unstemmed |
misc equine piroplasmosis misc <i<Babesia caballi</i< misc IFAT misc nested PCR misc risk factors misc Medicine misc R |
topic_browse |
misc equine piroplasmosis misc <i<Babesia caballi</i< misc IFAT misc nested PCR misc risk factors misc Medicine misc R |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Pathogens |
hierarchy_parent_id |
732627885 |
hierarchy_top_title |
Pathogens |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)732627885 (DE-600)2695572-6 |
title |
Serological and Molecular Prevalence of <em<Babesia caballi</em< in Apparently Healthy Horses in Israel |
ctrlnum |
(DE-627)DOAJ031234720 (DE-599)DOAJb3cca79427944cc09f98a5fbb03a7659 |
title_full |
Serological and Molecular Prevalence of <em<Babesia caballi</em< in Apparently Healthy Horses in Israel |
author_sort |
Sharon Tirosh-Levy |
journal |
Pathogens |
journalStr |
Pathogens |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2021 |
contenttype_str_mv |
txt |
author_browse |
Sharon Tirosh-Levy Monica L. Mazuz Igor Savitsky Dana Pinkas Yuval Gottlieb Amir Steinman |
container_volume |
10 |
format_se |
Elektronische Aufsätze |
author-letter |
Sharon Tirosh-Levy |
doi_str_mv |
10.3390/pathogens10040445 |
author2-role |
verfasserin |
title_sort |
serological and molecular prevalence of <em<babesia caballi</em< in apparently healthy horses in israel |
title_auth |
Serological and Molecular Prevalence of <em<Babesia caballi</em< in Apparently Healthy Horses in Israel |
abstract |
<i<Babesia caballi</i< is a tick-borne hemoparasite of equines and one of the causative agents of equine piroplasmosis, which poses a great concern for the equine industry regarding animal welfare and international horse movement. The parasite is endemic in Israel; however, its seroprevalence in the area was never evaluated due to antigenic heterogenicity in the gene used in the commercially available kit. Blood samples were collected from 257 horses at 19 farms throughout the country and screened for the presence of anti-<i<B. caballi</i< antibodies via an indirect immunofluorescent antibody test (IFAT) and for the presence of parasite DNA by nested PCR. The seroprevalence of <i<B. caballi</i< was 69.6% and its molecular prevalence was 9.7%. The geographical area, horse’s sex, breed, housing, exposure to ticks, and specifically to <i<Hyalomma marginatum</i<, and co-infection with <i<Theileria equi</i< were found to be significantly associated with serologic exposure in univariable analysis, while the geographical area and horses’ sex remained significant in the multivariable analysis. The results of this study demonstrate a high level of exposure to <i<B. caballi</i< and identify important risk factors for infection. The difference between the serological and molecular prevalence, probably related to parasite clearance, is also highlighted. |
abstractGer |
<i<Babesia caballi</i< is a tick-borne hemoparasite of equines and one of the causative agents of equine piroplasmosis, which poses a great concern for the equine industry regarding animal welfare and international horse movement. The parasite is endemic in Israel; however, its seroprevalence in the area was never evaluated due to antigenic heterogenicity in the gene used in the commercially available kit. Blood samples were collected from 257 horses at 19 farms throughout the country and screened for the presence of anti-<i<B. caballi</i< antibodies via an indirect immunofluorescent antibody test (IFAT) and for the presence of parasite DNA by nested PCR. The seroprevalence of <i<B. caballi</i< was 69.6% and its molecular prevalence was 9.7%. The geographical area, horse’s sex, breed, housing, exposure to ticks, and specifically to <i<Hyalomma marginatum</i<, and co-infection with <i<Theileria equi</i< were found to be significantly associated with serologic exposure in univariable analysis, while the geographical area and horses’ sex remained significant in the multivariable analysis. The results of this study demonstrate a high level of exposure to <i<B. caballi</i< and identify important risk factors for infection. The difference between the serological and molecular prevalence, probably related to parasite clearance, is also highlighted. |
abstract_unstemmed |
<i<Babesia caballi</i< is a tick-borne hemoparasite of equines and one of the causative agents of equine piroplasmosis, which poses a great concern for the equine industry regarding animal welfare and international horse movement. The parasite is endemic in Israel; however, its seroprevalence in the area was never evaluated due to antigenic heterogenicity in the gene used in the commercially available kit. Blood samples were collected from 257 horses at 19 farms throughout the country and screened for the presence of anti-<i<B. caballi</i< antibodies via an indirect immunofluorescent antibody test (IFAT) and for the presence of parasite DNA by nested PCR. The seroprevalence of <i<B. caballi</i< was 69.6% and its molecular prevalence was 9.7%. The geographical area, horse’s sex, breed, housing, exposure to ticks, and specifically to <i<Hyalomma marginatum</i<, and co-infection with <i<Theileria equi</i< were found to be significantly associated with serologic exposure in univariable analysis, while the geographical area and horses’ sex remained significant in the multivariable analysis. The results of this study demonstrate a high level of exposure to <i<B. caballi</i< and identify important risk factors for infection. The difference between the serological and molecular prevalence, probably related to parasite clearance, is also highlighted. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
4, p 445 |
title_short |
Serological and Molecular Prevalence of <em<Babesia caballi</em< in Apparently Healthy Horses in Israel |
url |
https://doi.org/10.3390/pathogens10040445 https://doaj.org/article/b3cca79427944cc09f98a5fbb03a7659 https://www.mdpi.com/2076-0817/10/4/445 https://doaj.org/toc/2076-0817 |
remote_bool |
true |
author2 |
Monica L. Mazuz Igor Savitsky Dana Pinkas Yuval Gottlieb Amir Steinman |
author2Str |
Monica L. Mazuz Igor Savitsky Dana Pinkas Yuval Gottlieb Amir Steinman |
ppnlink |
732627885 |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.3390/pathogens10040445 |
up_date |
2024-07-03T19:29:37.918Z |
_version_ |
1803587397008490496 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ031234720</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240412184710.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/pathogens10040445</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ031234720</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJb3cca79427944cc09f98a5fbb03a7659</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Sharon Tirosh-Levy</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Serological and Molecular Prevalence of <em<Babesia caballi</em< in Apparently Healthy Horses in Israel</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a"><i<Babesia caballi</i< is a tick-borne hemoparasite of equines and one of the causative agents of equine piroplasmosis, which poses a great concern for the equine industry regarding animal welfare and international horse movement. The parasite is endemic in Israel; however, its seroprevalence in the area was never evaluated due to antigenic heterogenicity in the gene used in the commercially available kit. Blood samples were collected from 257 horses at 19 farms throughout the country and screened for the presence of anti-<i<B. caballi</i< antibodies via an indirect immunofluorescent antibody test (IFAT) and for the presence of parasite DNA by nested PCR. The seroprevalence of <i<B. caballi</i< was 69.6% and its molecular prevalence was 9.7%. The geographical area, horse’s sex, breed, housing, exposure to ticks, and specifically to <i<Hyalomma marginatum</i<, and co-infection with <i<Theileria equi</i< were found to be significantly associated with serologic exposure in univariable analysis, while the geographical area and horses’ sex remained significant in the multivariable analysis. The results of this study demonstrate a high level of exposure to <i<B. caballi</i< and identify important risk factors for infection. The difference between the serological and molecular prevalence, probably related to parasite clearance, is also highlighted.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">equine piroplasmosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<Babesia caballi</i<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">IFAT</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">nested PCR</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">risk factors</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Monica L. Mazuz</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Igor Savitsky</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Dana Pinkas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yuval Gottlieb</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Amir Steinman</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Pathogens</subfield><subfield code="d">MDPI AG, 2012</subfield><subfield code="g">10(2021), 4, p 445</subfield><subfield code="w">(DE-627)732627885</subfield><subfield code="w">(DE-600)2695572-6</subfield><subfield code="x">20760817</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:4, p 445</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/pathogens10040445</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/b3cca79427944cc09f98a5fbb03a7659</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/2076-0817/10/4/445</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2076-0817</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">2021</subfield><subfield code="e">4, p 445</subfield></datafield></record></collection>
|
score |
7.4004107 |